You really are a squid. Quit while you only look half baked.
And overarching all of that the context was that TLX is in with Novartis on the issue not because illucix is being copied but because therapy drugs are being copied.
If you think that won't affect Cu6 in the future you're a dope. If this company grows and becomes a big player it too will be using antibody conjugates with isotopes which aren't able to be renally excreted like alphas where patent protection is impossible.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)